| Title |
Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, November 2019
|
| DOI | 10.1186/s40425-019-0769-8 |
| Pubmed ID | |
| Authors |
Alice Newey, Beatrice Griffiths, Justine Michaux, Hui Song Pak, Brian J. Stevenson, Andrew Woolston, Maria Semiannikova, Georgia Spain, Louise J. Barber, Nik Matthews, Sheela Rao, David Watkins, Ian Chau, George Coukos, Julien Racle, David Gfeller, Naureen Starling, David Cunningham, Michal Bassani-Sternberg, Marco Gerlinger |
X Demographics
The data shown below were collected from the profiles of 47 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 23% |
| United Kingdom | 11 | 23% |
| Canada | 2 | 4% |
| Italy | 2 | 4% |
| Spain | 2 | 4% |
| Hong Kong | 1 | 2% |
| Portugal | 1 | 2% |
| Sweden | 1 | 2% |
| Japan | 1 | 2% |
| Other | 1 | 2% |
| Unknown | 14 | 30% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 22 | 47% |
| Members of the public | 20 | 43% |
| Practitioners (doctors, other healthcare professionals) | 3 | 6% |
| Science communicators (journalists, bloggers, editors) | 2 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 140 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 140 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 29 | 21% |
| Researcher | 25 | 18% |
| Student > Master | 10 | 7% |
| Student > Bachelor | 10 | 7% |
| Student > Postgraduate | 7 | 5% |
| Other | 20 | 14% |
| Unknown | 39 | 28% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 39 | 28% |
| Agricultural and Biological Sciences | 18 | 13% |
| Immunology and Microbiology | 16 | 11% |
| Medicine and Dentistry | 13 | 9% |
| Unspecified | 4 | 3% |
| Other | 14 | 10% |
| Unknown | 36 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 December 2019.
All research outputs
#1,100,582
of 25,837,817 outputs
Outputs from Journal for Immunotherapy of Cancer
#251
of 3,485 outputs
Outputs of similar age
#26,163
of 480,029 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#9
of 98 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,485 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 480,029 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 98 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.